Search Results

Naton brings a series of products to the Symposium on Diagnosis and Treatment Standards and New Technologies for Orbital Diseases and Eye Trauma

• Source: China Business News (China), July 27, 2023 News, 3pp

Record details

Ophthalmoplasty unit inaugurated

• Authors : By:Madhuri Kumar

• Source: Times of India, The (Mumbai, India), May 25, 2009 Patna, 2pp

Record details

The Times of India:; Ophthalmoplasty unit inaugurated

• Authors : By:Madhuri Kumar

• Source: Times of India, The (Mumbai, India), May 26, 2009, 2pp

Record details

Diagnosing a stroke; Special goggles track eye movement to determine cause of key symptom - vertigo

• Authors : By:THOMAS BRUCH

• Source: Peoria Journal Star, The (IL), March 18, 2015 FEATURES All, 4pp

Record details

Clinical Trial: A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

• Source: Health Daily Digest [HT Digital] (India), January 26, 2024, 1pp

Record details

Clinical Trial: A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

• Source: US Fed News (USA), January 26, 2024, 1pp

Record details

'Tech-driven healthcare holds key to future'

• Authors : By:Special Correspondent

• Source: Hindu, The (Chennai, India), August 20, 2016 TAMIL NADU, 2pp

Record details

An eye on canine orbital disease: Causes, diagnostics, and treatment

• Authors : By:Juliet R. Gionfriddo, DVM, MS, DACVO - Juliet R. Gionfriddo, DVM, MS, DACVO, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523.; William C. Aaroe, DVM - William C. Aaroe, DVM, Fisher's Peak Veterinary Clinic, 1617 Santa Fe Trail Drive, Trinidad, CO 81082.

• Source: Veterinary Medicine (USA), November 1, 2013 Features, 12pp

Record details

Innovent released the results of two clinical studies of IBI311 (an anti-IGF-1R monoclonal antibody) in oral presentations at the Asia-Pacific Academy of Ophthalmology Congress and International Congress of Endocrinology 2024

• Source: PR Newswire Asia, March 6, 2024, 7pp

Record details

Innovent Biologics meets primary endpoint for Phase 3 clinical trial, plans to submit NDA; A treatment option for thyroid eye disease may be on its way to finalization in China with the positive endpoint results from a Phase 3 clinical trial of IBI311, a recombinant anti-insulin-like growth factor 1 receptor antibody.

• Authors : By:Jordana Joy, Associate Editor

• Source: Optometry Times (USA), February 28, 2024 News, 4pp

Record details